Early Access

10-QPeriod: Q3 FY2014

Zoetis Inc. Quarterly Report for Q3 Ended Sep 28, 2014

Filed November 10, 2014For Securities:ZTS

Summary

Zoetis Inc. reported solid financial results for the nine months ended September 28, 2014, with total revenue increasing by 5% to $3,465 million and net income attributable to Zoetis Inc. rising by 15% to $457 million. This growth was primarily driven by a 6% increase in operational revenue, stemming from strong performance in both livestock and companion animal segments, particularly in the U.S. and emerging markets. The company demonstrated improved cost management, with Selling, General, and Administrative (SG&A) expenses decreasing by 1% over the period. Despite a $54 million unfavorable impact from foreign exchange, Zoetis showcased resilience. The company also maintained a healthy liquidity position, with cash and cash equivalents at $598 million and a strong current ratio of 3.36:1. The company provided an updated financial guidance for the full year 2014, projecting revenue between $4.7 and $4.75 billion and adjusted diluted EPS between $1.50 and $1.54, indicating continued confidence in its business outlook.

Financial Statements
Beta
Revenue$1.21B
Cost of Revenue$434.00M
Gross Profit$776.00M
SG&A Expenses$394.00M
Operating Expenses$970.00M
Interest Expense$29.00M
Net Income$167.00M
EPS (Basic)$0.33
EPS (Diluted)$0.33
Shares Outstanding (Basic)501.45M
Shares Outstanding (Diluted)502.44M

Key Highlights

  • 1Revenue for the nine months ended September 28, 2014, increased by 5% to $3,465 million, compared to $3,307 million in the prior year period.
  • 2Net income attributable to Zoetis Inc. grew by 15% to $457 million for the nine months ended September 28, 2014, up from $399 million in the comparable period.
  • 3Operational revenue, excluding foreign exchange impacts, increased by 6% year-over-year for the nine-month period.
  • 4SG&A expenses decreased by 1% for the nine months ended September 28, 2014, reflecting effective cost management.
  • 5The company reported $598 million in cash and cash equivalents as of September 28, 2014.
  • 6Zoetis provided full-year 2014 guidance, forecasting revenue between $4.7 and $4.75 billion and adjusted diluted EPS between $1.50 and $1.54.

Frequently Asked Questions